"Where Everyone Has an MBA"
Tel: (612) 246-4616
Frequently Asked Questions
- Frequently Asked Questions
- User Testimonials
Ampio Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Ampio Pharmaceuticals Inc
Here's Why Ampio Pharmaceuticals Dropped as Much as 18.8% Today
- Feb 16th, 2018 1:21 pm
Is Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) Still A Cheap Healthcare Stock?
- Feb 13th, 2018 12:39 pm
Research Report Identifies Del Frisco's Restaurant Group, Capital Senior Living, Bazaarvoice, Macerich, Ampio Pharmaceuticals, and Diamondrock Hospitality with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
- Jan 26th, 2018 5:30 am
Is Ampio Pharmaceuticals Inc’s (NYSEMKT:AMPE) CEO Salary Justified?
- Jan 22nd, 2018 1:00 pm
Ampio Update of J.P. Morgan Meeting Events and Disease Modification Discussions
- Jan 16th, 2018 6:30 am
What Does Ampio Pharmaceuticals Inc’s (NYSEMKT:AMPE) Ownership Structure Look Like?
- Jan 15th, 2018 12:51 pm
Ampio Presentation at J.P. Morgan Healthcare Conference made available to all Shareholders
- Jan 8th, 2018 6:30 am
Did Ampio Pharmaceuticals Inc’s (NYSEMKT:AMPE) Recent Earnings Growth Beat The Trend?
- Jan 4th, 2018 12:50 pm
Here's Why Ampio Pharmaceuticals Sank as Much as 13.5% Today
- Jan 3rd, 2018 2:36 pm
3 Biotech Stocks That Soared This Week: Are They Buys?
- Dec 30th, 2017 8:37 am
Why Ampio Pharmaceuticals Rose as Much as 15% Today
- Dec 28th, 2017 10:31 am
Ampio Pharmaceuticals Inc (AMPE) Rallies as Knee Osteoarthritis Drug Findings Cheer
- Dec 14th, 2017 9:29 am
Ampio Pharmaceuticals Reports Positive Results for both Primary and Secondary Endpoints of Pivotal Phase 3 Trial of Ampion™ in Severe Osteoarthritis-of-the Knee (OAK)
- Dec 14th, 2017 5:15 am
Today’s Research Reports on Stocks to Watch: Ampio Pharmaceuticals and Versartis
- Dec 4th, 2017 6:10 am
Ampio Pharmaceuticals Announces Engagement of LaVoieHealthScience for Integrated Public and Investor Relations
- Nov 30th, 2017 6:00 am
Today’s Research Reports on Stocks to Watch: Ampio Pharmaceuticals and Agenus Inc.
- Nov 24th, 2017 6:00 am
Ampio Announces Publication of Ampion™ Treatment of Severe Osteoarthritis of the Knee as a Feature Article in Orthopedics Peer-Reviewed Journal
- Nov 22nd, 2017 6:30 am
Ampio Pharmaceuticals, Inc. Announces Continued Listing Plan Accepted by NYSE American
- Nov 16th, 2017 4:25 pm
Ampio Announces Start of Open Label Extension Study to Support Commercial Label of Repeat Administration of Ampion™ in Severe Osteoarthritis of the Knee
- Nov 15th, 2017 6:30 am
Ampio Pharmaceuticals, Inc. Announces Closing of Registered Direct Offering
- Oct 18th, 2017 8:30 pm
Frequently Asked Questions
Terms and Conditions
Copyright © 2018 VentureLine
Website developed by Digital Solutions